Skip to content

Bluebird shares hit, Bellicum helped by report

April 19, 2017

bluebird bio (NASDAQ: BLUE) shares sold off a bit and Bellicum Pharma (NASDAQ: BLCM) shares spiked as a report made rounds through chatrooms commenting from Pluvia Securities Research that “Bellicum Pipeline Beats/Obsoletes BLUE’s Three Lead Drug Candidates” (LINK)

http://bit.ly/2olWfWN

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: